Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Rehan Akbani
Affiliation
The University of Texas MD Anderson Cancer Center
ORCID
Career Start Year
2013
Papers
69
H Index
45
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37744342
Chimeric RNAs reveal putative neoantigen peptides for developing tumor vaccines for breast cancer.
Front Immunol
2023
37744342
Chimeric RNAs reveal putative neoantigen peptides for developing tumor vaccines for breast cancer.
Front Immunol
2023
37527013
SETD2 Loss and ATR Inhibition Synergize to Promote cGAS Signaling and Immunotherapy Response in Renal Cell Carcinoma.
Clin Cancer Res
2023
37527013
SETD2 Loss and ATR Inhibition Synergize to Promote cGAS Signaling and Immunotherapy Response in Renal Cell Carcinoma.
Clin Cancer Res
2023
36332624
Tumor-intrinsic SIRPA promotes sensitivity to checkpoint inhibition immunotherapy in melanoma.
Cancer Cell
2022
36205581
RPPA SPACE: an R package for normalization and quantitation of Reverse-Phase Protein Array data.
Bioinformatics
2022
36332624
Tumor-intrinsic SIRPA promotes sensitivity to checkpoint inhibition immunotherapy in melanoma.
Cancer Cell
2022
35349735
Consensus subtypes of hepatocellular carcinoma associated with clinical outcomes and genomic phenotypes.
Hepatology
2022
35349735
Consensus subtypes of hepatocellular carcinoma associated with clinical outcomes and genomic phenotypes.
Hepatology
2022
36205581
RPPA SPACE: an R package for normalization and quantitation of Reverse-Phase Protein Array data.
Bioinformatics
2022
31504175
NExUS: Bayesian simultaneous network estimation across unequal sample sizes.
Bioinformatics
2020
32374631
Personalized Network Modeling of the Pan-Cancer Patient and Cell Line Interactome.
JCO Clin Cancer Inform
2020
31851289
SAMMI: a semi-automated tool for the visualization of metabolic networks.
Bioinformatics
2020
33157050
Large-Scale Characterization of Drug Responses of Clinically Relevant Proteins in Cancer Cell Lines.
Cancer Cell
2020
31504175
NExUS: Bayesian simultaneous network estimation across unequal sample sizes.
Bioinformatics
2020
31851289
SAMMI: a semi-automated tool for the visualization of metabolic networks.
Bioinformatics
2020
33157050
Large-Scale Characterization of Drug Responses of Clinically Relevant Proteins in Cancer Cell Lines.
Cancer Cell
2020
32374631
Personalized Network Modeling of the Pan-Cancer Patient and Cell Line Interactome.
JCO Clin Cancer Inform
2020
31068700
Next-generation characterization of the Cancer Cell Line Encyclopedia.
Nature
2019
31820388
Generation of Raw RPPA Data and Their Conversion to Analysis-Ready Data.
Adv Exp Med Biol
2019
31820386
Analytical Platforms 3: Processing Samples via the RPPA Pipeline to Generate Large-Scale Data for Clinical Studies.
Adv Exp Med Biol
2019
31509758
Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas.
Cell Rep
2019
31178611
Bayesian Hierarchical Varying-sparsity Regression Models with Application to Cancer Proteogenomics.
J Am Stat Assoc
2019
31477280
Identification and validation of a prognostic proteomic signature for cervical cancer.
Gynecol Oncol
2019
31068700
Next-generation characterization of the Cancer Cell Line Encyclopedia.
Nature
2019
31365877
Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas.
Cell Rep
2019
31201206
TCPA v3.0: An Integrative Platform to Explore the Pan-Cancer Analysis of Functional Proteomic Data.
Mol Cell Proteomics
2019
31820388
Generation of Raw RPPA Data and Their Conversion to Analysis-Ready Data.
Adv Exp Med Biol
2019
31820386
Analytical Platforms 3: Processing Samples via the RPPA Pipeline to Generate Large-Scale Data for Clinical Studies.
Adv Exp Med Biol
2019
31178611
Bayesian Hierarchical Varying-sparsity Regression Models with Application to Cancer Proteogenomics.
J Am Stat Assoc
2019
31201206
TCPA v3.0: An Integrative Platform to Explore the Pan-Cancer Analysis of Functional Proteomic Data.
Mol Cell Proteomics
2019
31509758
Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas.
Cell Rep
2019
31365877
Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas.
Cell Rep
2019
31477280
Identification and validation of a prognostic proteomic signature for cervical cancer.
Gynecol Oncol
2019
28918914
Analysis of Genomes and Transcriptomes of Hepatocellular Carcinomas Identifies Mutations and Gene Expression Changes in the Transforming Growth Factor-β Pathway.
Gastroenterology
2018
28918914
Analysis of Genomes and Transcriptomes of Hepatocellular Carcinomas Identifies Mutations and Gene Expression Changes in the Transforming Growth Factor-β Pathway.
Gastroenterology
2018
30268436
A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily.
Cell Syst
2018
29925010
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.
Cell Rep
2018
30297783
Personalized Integrated Network Modeling of the Cancer Proteome Atlas.
Sci Rep
2018
30096301
Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.
Cell
2018
30322867
Integrative Molecular Characterization of Malignant Pleural Mesothelioma.
Cancer Discov
2018
29898407
Integrated Molecular Characterization of Testicular Germ Cell Tumors.
Cell Rep
2018
29625049
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics.
Cell
2018
29625048
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.
Cell
2018
29716986
Credentialing Individual Samples for Proteogenomic Analysis.
Mol Cell Proteomics
2018
29622466
Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas.
Cancer Cell
2018
29622464
A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers.
Cancer Cell
2018
29617669
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.
Cell Rep
2018
29617664
Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas.
Cell Rep
2018
29617660
Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.
Cell Rep
2018
1 - 50 of 138
Column Actions
Search
Recommended Authors
Rohan Bareja
Case Western Reserve University
Career Start Year
2017
Number of shared co-authors
5
Raunak Shrestha
University of California San Francisco
Career Start Year
2014
Number of shared co-authors
4
Gian Luca Negri
British Columbia Cancer Research Institute
Career Start Year
2013
Number of shared co-authors
9
Elana J Fertig
Johns Hopkins University School of Medicine
Career Start Year
2010
Number of shared co-authors
15
Vladimir Ignatchenko
Margaret Cancer Center
Career Start Year
2009
Number of shared co-authors
1
Sungyong You
Cedars-Sinai Medical Center
Career Start Year
2008
Number of shared co-authors
1
Karolina Edlund
Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund
Career Start Year
2008
Number of shared co-authors
0
James C Costello
University of Colorado Anschutz Medical Campus
Career Start Year
2006
Number of shared co-authors
11
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year
2006
Number of shared co-authors
23
Pichai Raman
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year
2006
Number of shared co-authors
23
Bing Zhang
Baylor College of Medicine
Career Start Year
2005
Number of shared co-authors
23
Mariaelena Pierobon
Center for Applied Proteomics and Molecular Medicine, George Mason University
Career Start Year
2004
Number of shared co-authors
4
Steffen Durinck
Genentech Inc.
Career Start Year
2004
Number of shared co-authors
14
Benjamin Haibe-Kains
Princess Margaret Cancer Centre, University Health Network
Career Start Year
2004
Number of shared co-authors
11
Aik Choon Tan
Huntsman Cancer Institute, The University of Utah
Career Start Year
2003
Number of shared co-authors
3
Obi L Griffith
Washington University
Career Start Year
2003
Number of shared co-authors
52
Syed Haider
Institute of Cancer Research
Career Start Year
2002
Number of shared co-authors
15
Olivier Elemento
Meyer Cancer Center
Career Start Year
2002
Number of shared co-authors
50
Habib Hamidi
Genentech Inc.
Career Start Year
2002
Number of shared co-authors
4
Yidong Chen
The University of Texas Health Science Center at San Antonio
Career Start Year
2001
Number of shared co-authors
13
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year
2001
Number of shared co-authors
5
Lodewyk F A Wessels
University Medical Centre Mannheim, University of Heidelberg
Career Start Year
2000
Number of shared co-authors
25
Andrea Sboner
Institute for Computational Biomedicine
Career Start Year
2000
Number of shared co-authors
29
Tamar Geiger
Tel Aviv University
Career Start Year
2000
Number of shared co-authors
1
Aedin C Culhane
Dana-Farber Cancer Institute & Harvard School of Public Health
Career Start Year
1996
Number of shared co-authors
41
Donald J Johann
Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences
Career Start Year
1996
Number of shared co-authors
2
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year
1996
Number of shared co-authors
1
Arul M Chinnaiyan
University of Michigan Medical School.
Career Start Year
1993
Number of shared co-authors
51
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year
1989
Number of shared co-authors
12
Paul C Boutros
University of California los angeles
Career Start Year
1970
Number of shared co-authors
71
row(s) 1 - 30 of 30
Collaborators
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers
34
John N Weinstein
The University of Texas MD Anderson Cancer Center
Co-authored papers
27
Andrew D Cherniack
Dana-Farber Cancer Institute
Co-authored papers
26
Yiling Lu
Co-authored papers
23
Amy G Robertson
Present address: Dxige Research Inc.
Co-authored papers
22
Katherine A Hoadley
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Co-authored papers
20
Peter W Laird
Van Andel Institute
Co-authored papers
16
David A Wheeler
Baylor College of Medicine
Co-authored papers
15
Reanne Bowlby
Co-authored papers
14
Han Liang
MD Anderson Cancer Center
Co-authored papers
13
Roel G W Verhaak
Yale School of Medicine
Co-authored papers
11
Shiyun Ling
Co-authored papers
11
Hui Shen
Van Andel Institute
Co-authored papers
11
Matthew Meyerson
Broad Institute
Co-authored papers
10
Tara M Lichtenberg
Co-authored papers
10
Yuexin Liu
The University of Texas MD Anderson Cancer Center
Co-authored papers
10
Zhenlin Ju
Co-authored papers
10
Jaegil Kim
Co-authored papers
10
Christina Yau
University of California San Francisco
Co-authored papers
8
Chad J Creighton
Co-authored papers
8
Joshua M Stuart
University of California at Santa Cruz
Co-authored papers
8
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers
8
Jean Claude Zenklusen
National Cancer Institute
Co-authored papers
8
Wenbin Liu
Co-authored papers
8
Akinyemi I Ojesina
University of Alabama at Birmingham
Co-authored papers
7
Kristen Leraas
Nationwide Children's Hospital
Co-authored papers
7
Chandra Sekhar Pedamallu
Broad Institute
Co-authored papers
7
Toni K Choueiri
Dana-Farber Cancer Institute
Co-authored papers
7
Christopher C Benz
Buck Institute for Research on Aging
Co-authored papers
7
Alexander J Lazar
The University of Texas MD Anderson Cancer Center
Co-authored papers
7
1 - 30